High‐dose therapy improves the bone remodelling compartment canopy coverage and bone formation in multiple myeloma

E-ISSN： 1365-2141|171|3|355-365

ISSN： 0007-1048

Source： BRITISH JOURNAL OF HAEMATOLOGY, Vol.171, Iss.3, 2015-11, pp. : 355-365

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcome of patients with multiple myeloma and hypotension during high‐dose chemotherapy

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 6, 2015-06 ,pp. : E125-E127

John Wiley & Sons Inc

Access to resources Recommend Favorite

Causes of early death in multiple myeloma patients who are ineligible for high‐dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : E73-E74

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There an Indication for High-Dose Chemotherapy in the Treatment of Bone and Soft-Tissue Sarcoma?

Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. : 115-121

Karger

Access to resources Recommend Favorite

The effects of bortezomib on bone disease in patients with multiple myeloma

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 618-623

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of alendronate on bone metabolic indices and bone mineral density in patients treated with high-dose glucocorticoid: a prospective study

By Kaji H. Kuroki Y. Murakawa Y. Funakawa I. Funasaka Y. Kanda F. Sugimoto T.

Osteoporosis International, Vol. 21, Iss. 9, 2010-09 ,pp. : 1565-1571

Springer Publishing Company

Access to resources Recommend Favorite